AURA – GHK-Cu 70mg, Epithalon 10mg, Snap-8 10mg, KPV 10mg (100mg Blend)

$129.99

  • GHK-Cu: 70mg
  • Epithalon: 10mg
  • Snap-8: 10mg
  • KPV: 10mg
  • Total Material: 100mg
  • Appearance: Blue to purplish-blue lyophilized powder
  • Vial Size: 5mL
  • Four-component research formulation
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPAURA100 Categories: , Tags: , ,
Description

AURA Peptides – GHK-Cu / Epithalon / Snap-8 / KPV – Powerful 100mg Research Blend

AURA peptides is a four-component research formulation containing GHK-Cu 70mg, Epithalon 10mg, Snap-8 10mg, and KPV 10mg. The individually listed components provide 100mg total specified research material in a 5mL vial.

The material is described as a blue to purplish-blue lyophilized powder. Each component has separately supplied sequence and molecular specifications for laboratory identification and research documentation.

AURA Peptides 100mg Research Blend Overview

The supplied AURA formulation contains:

Specification GHK-Cu Epithalon Snap-8 KPV
Quantity 70mg 10mg 10mg 10mg
Molecular Formula C14H23CuN6O4 C14H22N4O9 C41H70N16O16S C16H30N4O4
Molecular Weight 340.384 g/mol 390.35 g/mol 1075.17 g/mol 342.43 g/mol
Supplied PubChem CID 73587 219042* 86080331* 125672*
CAS Number 89030-95-5 307297-39-8 868844-74-0 67727-97-3

Total Material: 100mg
Vial Size: 5mL
Appearance: Blue to purplish-blue lyophilized powder

*The supplied PubChem identifiers for Epithalon, Snap-8, and KPV do not match the destinations of their supplied PubChem hyperlinks. These discrepancies should be verified before publishing definitive database links.

GHK-Cu 70mg Specifications

The largest component of the AURA blend is GHK-Cu 70mg.

The supplied sequence is:

Gly-His-Lys

The supplied molecular formula is:

C14H23CuN6O4

Its molecular weight is 340.384 g/mol, supplied PubChem CID is 73587, and CAS number is 89030-95-5.

Researchers can examine records associated with the formula through the PubChem molecular formula search for C14H23CuN6O4.

The supplied molecular characteristics provide multiple reference points for documenting the GHK-Cu component.

Epithalon 10mg Specifications

The second specified component contains 10mg Epithalon.

Its supplied sequence is:

Ala-Glu-Asp-Gly

The supplied molecular formula is:

C14H22N4O9

The molecular weight is 390.35 g/mol, and CAS number is 307297-39-8.

The supplied PubChem CID is 219042. However, the accompanying PubChem URL points to compound 9941957 rather than 219042. The identifier/link combination should therefore be independently verified before being treated as a definitive database reference.

Snap-8 10mg Specifications

The third component contains 10mg Snap-8.

The supplied sequence is:

Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂

Its supplied molecular formula is:

C41H70N16O16S

The molecular weight is 1075.17 g/mol, the supplied PubChem CID is 86080331, and CAS number is 868844-74-0.

The provided hyperlink associated with the PubChem identifier points to compound 16132341 rather than the stated CID 86080331. This should be verified before publication.

KPV 10mg Specifications

The fourth component contains 10mg KPV.

Its supplied sequence is:

Lys-Pro-Val

The molecular formula is:

C16H30N4O4

The supplied molecular weight is 342.43 g/mol, PubChem CID is stated as 125672, and CAS number is 67727-97-3.

The supplied hyperlink associated with this identifier points to compound 73587 instead of 125672. The database identifier and supplied URL should therefore be verified before publication.

AURA Peptides Four-Component Research Format

The AURA peptides formulation combines:

GHK-Cu: 70mg
Epithalon: 10mg
Snap-8: 10mg
KPV: 10mg

Together, these quantities provide 100mg total specified research material.

GHK-Cu accounts for the largest listed portion of the formulation, while Epithalon, Snap-8, and KPV are each supplied at 10mg.

Research involving the complete four-component blend should be distinguished from experiments examining any component independently.

Snap-8 Research Material

The supplied keyword data shows notable search interest for snap-8 and snap 8.

Within AURA, Snap-8 represents 10mg of the 100mg total formulation.

For research identification, investigators should use the supplied sequence, molecular formula, molecular weight, CAS number, and verified database information rather than relying only on the abbreviated Snap-8 name.

The supplied information does not establish human cosmetic, therapeutic, or administration instructions, so none are inferred here.

Aura Peptide and Aura Peptides Search Terminology

Both aura peptide and aura peptides appear in the supplied keyword research.

For this product, the plural terminology accurately reflects a multi-component formulation containing four separately specified research materials.

Search terminology should nevertheless remain secondary to precise laboratory identification. Researchers should document the actual components, quantities, sequences, molecular characteristics, and experimental conditions associated with the material being investigated.

Aurora Peptides Search Context

The keyword aurora peptides also appears in the supplied research.

AURA is the supplied product name for this specific formulation. The provided product information does not establish “Aurora” as an alternative scientific name or synonym for AURA.

For that reason, aurora peptides should be treated as related search terminology rather than presented as an equivalent product identity.

Appearance and 5mL Vial Format

The supplied appearance of the AURA formulation is:

Blue to purplish-blue lyophilized powder

The product is supplied in a 5mL vial.

These are physical product specifications. Vial capacity does not independently establish final preparation volume, research concentration, or administration quantity.

No solvent, reconstitution procedure, storage requirement, or experimental concentration was supplied. Those parameters are therefore not being inferred.

Laboratory Research Considerations

Controlled investigation of AURA peptides should document the complete formulation as well as experiment-specific variables.

Relevant considerations may include:

  • Identity of all four components
  • Individual material quantities
  • Molecular characteristics
  • Physical appearance
  • Research model
  • Experimental concentration
  • Appropriate controls
  • Sample preparation
  • Exposure conditions
  • Analytical methodology
  • Observation period
  • Experimental endpoints
  • Reproducibility

Observations involving the complete blend should not automatically be attributed to a single component without an experimental design capable of supporting that conclusion.

Evaluating Scientific Literature

When reviewing research involving GHK-Cu, Epithalon, Snap-8, or KPV, investigators should distinguish studies of individual materials from research involving combination systems.

Relevant comparison factors include exact molecular identity, material format, experimental model, concentration, controls, study methodology, exposure conditions, analytical procedures, and measured endpoints.

Evidence involving an isolated component should not automatically be interpreted as evidence concerning the complete AURA formulation.

Related OROS Research Materials

Researchers can review VIP 10mg as a separately specified research material.

Another catalog option is 5-Amino-1MQ 50mg.

Researchers interested in multi-component formulations can review AEGIS – BPC-157 / TB-500 / KPV.

The catalog also includes AHK-Cu 100mg as a separately specified copper-associated research material.

Each product has its own specifications and should be evaluated independently.

Scientific Research Resources

Researchers can use PubChem to examine available molecular records and chemical identifiers.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

Because several supplied PubChem identifier/link combinations for this product conflict, database records should be independently verified before being incorporated into final research documentation.

Frequently Asked Questions

What are AURA peptides?

AURA peptides is the product designation used here for a four-component research blend containing GHK-Cu 70mg, Epithalon 10mg, Snap-8 10mg, and KPV 10mg.

How much total material is supplied?

The four listed components provide 100mg total specified material.

How much GHK-Cu does AURA contain?

The formulation contains 70mg GHK-Cu.

How much Snap-8 is included?

The supplied formulation contains 10mg Snap-8.

What is the appearance of the research material?

The supplied appearance is blue to purplish-blue lyophilized powder.

What size vial is supplied?

AURA is supplied in a 5mL vial.

What is the supplied GHK-Cu PubChem CID?

The supplied GHK-Cu PubChem CID is 73587.

Are all supplied PubChem links consistent with their stated CIDs?

No. The supplied Epithalon, Snap-8, and KPV identifier/link combinations contain discrepancies. Those records should be verified before the database links are published as definitive identifiers.

Research Use Disclaimer

This AURA peptides GHK-Cu / Epithalon / Snap-8 / KPV formulation is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Component quantities and vial capacity are research specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, cosmetic application, therapeutic use, diagnosis, treatment, athletic performance enhancement, bodybuilding, or veterinary application.

Additional information
Net Weight

100mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “AURA – GHK-Cu 70mg, Epithalon 10mg, Snap-8 10mg, KPV 10mg (100mg Blend)”

Your email address will not be published. Required fields are marked *